S. 4472, the Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026, passed the Senate on August 4, 2026.
S. 4472 — Accelerating Access to Critical Therapies for ALS Reauthori…
What it does
This bill extends the Accelerating Access to Critical Therapies for ALS Act through 2031, expanding the federal program that funds research grants for ALS treatments and therapies. It improves grant application requirements to ensure better data collection and safety reporting, broadens the program to include other rare neurodegenerative diseases, and adds new reporting requirements to track program effectiveness.
Quorum's transparency scan found no buried provisions in Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026.
What happens next
S. 4472 passed the Senate. It now moves to the other chamber.
Who is behind it
Filed by Lisa Murkowski. Cosponsored by Alex Padilla, Amy Klobuchar, Christopher Coons and Dave McCormick.